A detailed history of Financial Partners Group, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Financial Partners Group, LLC holds 1,788 shares of BIIB stock, worth $261,888. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,788
Previous 1,393 28.36%
Holding current value
$261,888
Previous $323 Million 7.33%
% of portfolio
0.13%
Previous 0.13%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$189.07 - $236.8 $74,682 - $93,536
395 Added 28.36%
1,788 $347 Million
Q2 2024

Jul 15, 2024

BUY
$190.52 - $236.72 $65,729 - $81,668
345 Added 32.92%
1,393 $323 Million
Q1 2024

Apr 17, 2024

BUY
$212.02 - $267.71 $222,196 - $280,560
1,048 New
1,048 $226 Million
Q4 2022

Feb 09, 2023

BUY
$252.44 - $306.72 $537,697 - $653,313
2,130 New
2,130 $590 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Financial Partners Group, LLC Portfolio

Follow Financial Partners Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Partners Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Partners Group, LLC with notifications on news.